![](/wp-content/uploads/2023/10/Screenshot-2023-10-02-at-6.59.20-PM.png)
$599
EASD 2023 Key Press Releases (Oct 03)
On the second day of EASD 2023, three key news items were observed from the Biden-Harris administration, Novo Nordisk, and Galectin Therapeutics. The following topics are covered below (hyperlinks to external items):